PET Imaging of the Human Brain at 2 µL Resolution with a Next-Generation Ultra-High-Resolution (UHR) Scanner

23 May 2024, 10:10
20m
La Biodola, Isola d'Elba

La Biodola, Isola d'Elba

Hotel Hermitage
Oral High-performance preclinical and organ-specific systems High-performance preclinical and organ-specific systems

Speaker

Francis Loignon-Houle (Université de Sherbrooke; Institute for Instrumentation in Molecular Imaging (i3M CSIC-UPV))

Description

PET is an ideal imaging modality for studying human brain biochemistry in vivo, but its potential is limited by its poor spatial resolution, which is currently well below the theoretical limit. The brain-dedicated UHR scanner is designed to achieve 2 µL volumetric resolution for accurate characterization of brain regions previously indistinguishable without MRI. Unlike most PET systems, the UHR relies on fully pixelated detectors with 1:1:1 coupling of the scintillation crystal, photodetector, and electronic readout to avoid degradation caused by light/charge sharing schemes. UHR physical performance was characterized using NEMA NU4-2008/NU2-2018 standards, while imaging performance was evaluated using phantoms and pilot studies in patients undergoing medically prescribed 18F-FDG scans. Point source OSEM reconstruction yields resolution better than 2 µL (<1.25 mm quasi-isotropic) up to ~3.5 cm from FOV center and remains below 2 mm radially up to ~7 cm. This is confirmed in images of hot spot phantoms in which 1.2 (1.6) mm hot spots can be resolved up to 5 (10) cm from center. Sensitivity, count rates and contrast recovery were also measured. In patients, small deep brain regions are visually delineated, particularly in the thalamus and brainstem, while hypermetabolic areas are visible along the cortical surface and regions of the subcortical anatomy rarely seen as separate entities, such as subthalamic and brainstem nuclei, which can now be better quantified in UHR images.

Field Systems and applications

Primary author

Roger Lecomte (Université de Sherbrooke)

Co-authors

Vincent Doyon (Université de Sherbrooke) Mr Étienne Auger (IR&T Inc.) Dr Christian Thibaudeau (IR&T Inc.) Mr Jean-François Beaudoin (CIMS/CRCHUS) Dr Jean-Daniel Leroux (Novalgo Inc.) Maxime Toussaint (Université de Sherbrooke) Mr Maxime Gaudreault (Université de Sherbrooke) Francis Loignon-Houle (Université de Sherbrooke; Institute for Instrumentation in Molecular Imaging (i3M CSIC-UPV)) Dr Otman Sarrhini (CIMS/CRCHUS) Dr Étienne Croteau (CIMS/CRCHUS) Mr Éric Lavallée (CIMS/CRCHUS) Dr Stephan Blinder (McGill University) Prof. Jean-Paul Soucy (McGill University) Udunna Anazodo (Department of Neurology and Neurosurgery, McGill University)

Presentation materials